| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/14/2002 | WO2001055410A3 Ceramidase compositions and methods based thereon |
| 03/14/2002 | WO2001055358A3 Phosphodiesterases |
| 03/14/2002 | WO2001055312A3 Nucleic acids, proteins, and antibodies |
| 03/14/2002 | WO2001053524A3 Cancer associated genes and their products |
| 03/14/2002 | WO2001051512A3 Human and parasite orphan receptor proteins |
| 03/14/2002 | WO2001049325A3 Gene therapy to promote angiogenesis and/or the treatment of heart failure |
| 03/14/2002 | WO2001048162A3 Method for the production of vitamin a |
| 03/14/2002 | WO2001047551A3 Eliciting antibodies specific for hepatitis c virus (hcv) |
| 03/14/2002 | WO2001044497A3 Protein kinase regulation |
| 03/14/2002 | WO2001040472A3 Streptococcus pneumoniae antigens |
| 03/14/2002 | WO2001027267A3 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions |
| 03/14/2002 | WO2001023572A3 Polynucleotides and polypeptides encoded thereby |
| 03/14/2002 | WO2001023001A3 Rapid peg-modification |
| 03/14/2002 | WO2001021651A3 Novel human protease inhibitor-like proteins and polynucleotides encoding the same |
| 03/14/2002 | WO2000066608A9 Tumor necrosis factor-gamma |
| 03/14/2002 | WO2000065028A9 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 03/14/2002 | WO2000056899A9 Dsp-2 dual-specificity map kinase phosphatase |
| 03/14/2002 | WO2000055335A9 Pseudotyped lentiviral vectors and uses thereof |
| 03/14/2002 | WO2000053742A9 Polynucleotides and proteins encoded thereby |
| 03/14/2002 | WO1997003998A9 Modulators of the function of fas receptors and other proteins |
| 03/14/2002 | US20020032915 Detecting size defect in animal infants; obtain tissue biopsy, monitor expression of somatomedins in sample, amplified somatomedin concentration indicates potential size defect in animals |
| 03/14/2002 | US20020032324 Process for the preparation of endotoxin-free or endotoxin-depleted nucleic acids and/or oligonucleotides for gene therapy |
| 03/14/2002 | US20020032323 Polynucleotide and polypeptide sequence information stored on computer readable media |
| 03/14/2002 | US20020032307 Hepadnavirus pre-S protein fragments |
| 03/14/2002 | US20020032167 Increasing dwell time of fluid in a targeted area, administration of vascular permeablizing agent, and administration of a viral vector containing a gene expression cassette of interest |
| 03/14/2002 | US20020032165 Microspheres and adjuvants for DNA vaccine delivery |
| 03/14/2002 | US20020032164 For sanitizing surfaces |
| 03/14/2002 | US20020032163 Administering to subject a high dosage of an inactivated virus prior to administration of of a live recombinant virus carrying a transgene |
| 03/14/2002 | US20020032162 For inducing immune responses in a vertebrate against Mycobacterial epitopes |
| 03/14/2002 | US20020031831 Plasmid for use in vaccination and gene therapy |
| 03/14/2002 | US20020031824 Preferential migration of and association of progenitor cells; obtain cells, administer cells to human, detect preferential binding |
| 03/14/2002 | US20020031823 Use of trans-activation and CIS-activation to modulate the persistence of expression of a transgene |
| 03/14/2002 | US20020031803 Expression system for production of therapeutic proteins |
| 03/14/2002 | US20020031802 Novel seven transmembrane proteins and polynucleotides encoding the same |
| 03/14/2002 | US20020031797 Novel nucleic acid isolated from tetrahymena which codes for a triterpenoid cyclase, its production, and use |
| 03/14/2002 | US20020031785 Splice variants of brca1 and brca2 |
| 03/14/2002 | US20020031763 Complexing |
| 03/14/2002 | US20020031527 Bulking agents, cryoprotectants and lyoprotectants added for storage stability |
| 03/14/2002 | US20020031521 Method of DNA transfer |
| 03/14/2002 | US20020031512 Inhibiting immunological activation of keratinocytes by administering molecule that binds to CD40 but does not activate CD40-expressing keratinocytes |
| 03/14/2002 | US20020031508 Administering inducer of P-selectin activity such that hemostasis occurs |
| 03/14/2002 | US20020031501 Cardiomyocytes for heart muscles damaged in heart attacks |
| 03/14/2002 | US20020031500 Delivery of therapeutic biologicals from implantable tissue matrices |
| 03/14/2002 | US20020031499 Defective recombinant adenoviruses expressing cytokines for antitumor treatment |
| 03/14/2002 | US20020031496 Therapy for cellular accumulation in chronic inflammatory diseases |
| 03/14/2002 | US20020031493 Recombinant adenoviruses coding for glial-derived cell neurotrophic factor (gdnf) |
| 03/14/2002 | DE10043702A1 New antisense oligonucleotides and ribozymes, useful for treating e.g. pain and for diagnosis, are directed against mRNA for vanilloid-family receptors |
| 03/14/2002 | DE10043227A1 Neuartiges entwicklungsbiologisches Gen Novel biological developmental gene |
| 03/14/2002 | DE10043124A1 Verfahren zur Diagnostik von neuronalen Erkrankungen sowie zur Behandlung der defizienten primären Hämostase Method for the diagnosis of neural disorders and for the treatment of primary hemostasis deficiency |
| 03/14/2002 | DE10042137A1 sgk2 und sgk3 als diagnostische und therapeutische Targets sgk2 and sgk3 as diagnostic and therapeutic targets |
| 03/14/2002 | CA2422506A1 Inducing cellular immune responses to hepatitis b virus using peptide and nucleic acid compositions |
| 03/14/2002 | CA2421842A1 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 03/14/2002 | CA2421783A1 Receptor in the edb fibronectin domain |
| 03/14/2002 | CA2421723A1 Stat3 agonists and antagonists and therapeutic uses thereof |
| 03/14/2002 | CA2421584A1 Gene therapy for cardiac arrythmias |
| 03/14/2002 | CA2421451A1 Method and system for myocardial infarction repair |
| 03/14/2002 | CA2421380A1 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | CA2421274A1 Method for down-regulating ige |
| 03/14/2002 | CA2421271A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | CA2421265A1 Molecules for diagnostics and therapeutics |
| 03/14/2002 | CA2421251A1 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
| 03/14/2002 | CA2421200A1 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | CA2421195A1 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | CA2421191A1 Methods and compositions for in vitro targeting |
| 03/14/2002 | CA2419943A1 Secretory molecules |
| 03/14/2002 | CA2419563A1 Chimeric antisense of arabinofuranose analogue and deoxyribose nucleotides |
| 03/14/2002 | CA2417660A1 Vp22 protein/nucleic acid aggregates, uses thereof |
| 03/13/2002 | EP1186667A1 Paramyxoviridae virus vector defective in envelope gene |
| 03/13/2002 | EP1186661A1 Identification of the major capacitative calcium channel in antigen presenting cells and uses thereof |
| 03/13/2002 | EP1186299A1 The diagnosis, prevention, and/or succesful treatment of atherosclerosis, infectious diseases, and disturbances in the immune system |
| 03/13/2002 | EP1185700A1 49 human secreted proteins |
| 03/13/2002 | EP1185698A1 Automated nucleic acid compaction device |
| 03/13/2002 | EP1185696A1 Antisense oligonucleotide modulation of human protein kinase c-delta expression |
| 03/13/2002 | EP1185694A1 49 human secreted proteins |
| 03/13/2002 | EP1185681A1 High specificity hairpin antisense oligonucleotides |
| 03/13/2002 | EP1185674A1 Cationic lipids for gene transfer and preparation method thereof |
| 03/13/2002 | EP1185662A2 Dna vaccines for pets and sport animals |
| 03/13/2002 | EP1185659A2 Dna pcv vaccine |
| 03/13/2002 | EP1185655A1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf) |
| 03/13/2002 | EP1185652A2 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 03/13/2002 | EP1185645A1 Adipocyte complement related protein homolog zacrp7 |
| 03/13/2002 | EP1185642A2 Compositions and methods for the treatment of tumor |
| 03/13/2002 | EP1185639A1 Prostate-specific gene, pcgem1, and methods of using pcgem1 to detect, treat, and prevent prostate cancer |
| 03/13/2002 | EP1185637A1 ANTISENSE TO i c-myc /i FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE |
| 03/13/2002 | EP1185628A2 Isolation of a human retrovirus |
| 03/13/2002 | EP1185615A2 Recombinant influenza viruses for vaccines and gene therapy |
| 03/13/2002 | EP1185556A1 Use of soluble protein molecules expressed by the pancreas and kidney glomerulus |
| 03/13/2002 | EP1185555A2 Compositions isolated from skin cells and methods for their use |
| 03/13/2002 | EP1185547A2 Gene expression modulated in gastrointestinal inflammation |
| 03/13/2002 | EP1185545A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics |
| 03/13/2002 | EP1185543A1 50 human secreted proteins |
| 03/13/2002 | EP1185306A1 Use of viral vectors and charged molecules for gene therapy |
| 03/13/2002 | EP1185305A1 Ligand-conjugated oligomeric compounds |
| 03/13/2002 | EP1185304A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
| 03/13/2002 | EP1185303A1 Inhibition of gastric acid production and/or secretion |
| 03/13/2002 | EP1185299A1 Use of antibodies against cd20 for the treatment of the graft versus host disease |
| 03/13/2002 | EP1185298A2 Prevention and treatment of amyloidogenic disease |
| 03/13/2002 | EP1185297A2 Streptococcus pneumoniae proteins and vaccines |
| 03/13/2002 | EP1185296A2 Prevention and treatment of amyloidogenic disease |
| 03/13/2002 | EP1185285A1 49 human secreted proteins |